ABSTRACT
INTRODUCTION
Deep infiltrating endometriosis (DIE) is defined as endometriotic lesions penetrating the retroperitoneal space or walls of the pelvic organs 1 . The pain associated with DIE is the major clinical problem of the disease, manifesting as dysmenorrhea, dyspareunia, chronic pelvic pain, dysuria and dyschezia 1 . Of note, endometriosis is also associated with alteration in sexual function and urinary and rectal dysfunction [2] [3] [4] [5] [6] [7] [8] . Pelvic floor muscle (PFM) dysfunction seems to play an important role in the pathophysiology of pain symptoms and alterations in pelvic organ function in women with pelvic pain, such as that associated with endometriosis 7, [9] [10] [11] [12] . A recent case-control study showed that women with DIE have an increased prevalence of PFM spasms when compared with women without endometriosis 13 . However, assessment of the PFM using digital palpation or electromyography may elicit pain that may provoke a muscle contraction and result in significant bias in the findings obtained 10 . Three-dimensional (3D) and four-dimensional (4D) transperineal ultrasound measurement of levator hiatal area (LHA) in both static and dynamic maneuvers (PFM contraction and Valsalva maneuver) has been shown to be a valid, reliable and non-invasive method for assessing pelvic morphometry [14] [15] [16] . Previous investigations of PFM tone and strength assessed with transperineal ultrasound have been described in women affected by pain, such as vestibulodynia and pelvic girdle pain 10, 11, 17 .
The aim of this study was to evaluate static and dynamic morphometry of the PFM using 3D/4D transperineal ultrasound in women affected by DIE, compared with asymptomatic healthy women.
METHODS

Study population
This pilot prospective study was conducted between March and November 2015 at our tertiary center. Fifty consecutive nulliparous women with a diagnosis of DIE were included in the study group. At our center, diagnosis of DIE is based on clinical and transvaginal ultrasound examinations and, when necessary, magnetic resonance imaging and transabdominal ultrasound. All patients in the study group underwent laparoscopic excision of the DIE, and diagnosis of DIE was confirmed by histological examination of the surgical specimens. Thirty-five age-matched nulliparous healthy volunteers -who did not show any clinical or sonographic signs of endometriosis -were enrolled as a control group.
Exclusion criteria were: age < 18 years or > 45 years, current or previous pregnancy, postmenopausal status, other identifiable cause of pelvic pain or pelvic floor dysfunction in order to minimize bias (pelvic organ prolapse, pelvic inflammatory disease, interstitial cystitis, irritable bowel disease, inflammatory bowel disease, vulvodynia, active urinary or vaginal infection, diagnosis of genital malignancy or other cause of chronic pelvic pain, congenital or acquired abnormalities of the pelvis or pelvic floor, previous surgery for DIE) and hormonal therapy within 3 months before surgery in order to avoid any interference of the therapy with PFM status.
For each woman, data on preoperative medical history (age, body mass index, previous surgery, pain symptoms), surgical findings and histology were collected. In the study group, the diagnosis of DIE was confirmed by histological examination of the surgical specimens.
Patients gave written informed consent to participate in the study, and approval of the study protocol was obtained from the local ethics committee (196/2015/O/Sper).
Ultrasound technique
Before proceeding with transperineal ultrasound, a vaginal examination to evaluate a correct PFM contraction was performed. 3D and 4D transperineal ultrasound examinations were performed before surgery to evaluate PFM morphometry at rest, on maximum PFM contraction and on maximum Valsalva maneuver, as described previously 15, 16 . All scans from both groups were obtained by the same experienced operator (A.Y.). A Voluson E6 system (GE Medical Systems, Zipf, Austria) with a RAB 8-4-MHz volume transducer was used for all acquisitions. The 3D volume was acquired with the woman in the modified lithotomy position and with an empty bladder, using the 'high quality' setting and a wide ) who had at least 2 years of experience in pelvic floor ultrasound 14, 18 . The LHA, anteroposterior (AP) diameter and left-right (LR) transverse diameter were analyzed at rest, on maximum PFM contraction and on maximum Valsalva maneuver (Figures 1-3 ). The LHA was delimited by the puborectalis muscle, symphysis pubis and inferior pubic ramus. Within this border, the levator hiatus AP distance corresponded to the levator hiatus AP diameter, and the transverse distance, measured at the widest part of the levator hiatus, was defined as the levator hiatus LR transverse diameter.
These measured parameters have been studied previously for their properties and demonstrated good test-retest, intraobserver and interobserver reliability. Moreover, they have been shown to be comparable with different pelvic floor assessment techniques and diagnostic tools 15, 16, [19] [20] [21] . During dynamic examination, patients were instructed not to be inhibited by the presence of urinary, fecal or flatus incontinence, in order to achieve maximum pushing effort for at least 6 s 22 . Data from the most effective Valsalva maneuver and PFM contraction volume, defined as the volume showing the most organ displacement, were utilized. The changes in morphometry during PFM contraction or on Valsalva maneuver were calculated as a percentage change from the baseline, i.e. levator hiatus narrowing = ((levator hiatus at rest − levator hiatus on contraction)/levator hiatus at rest) × 100.
During Valsalva maneuver, we evaluated the presence of simultaneous levator ani muscle (LAM) contraction (coactivation), identifiable as a smaller AP diameter than in the resting state (Figure 4) , as reported bÿ Orno and Dietz 23 . LAM coactivation was considered persistent when it was observed on three consecutive attempts, despite provision of visual biofeedback during the Valsalva maneuvers to try to counter this.
All volumes were subsequently evaluated offline with dedicated software (4DView 9.0; GE Medical Systems) by investigators blinded to the clinical data.
Statistical analysis
Continuous data are expressed as mean ± SD or median (range), and categorical variables as n (%). Unpaired Student's t-test was used to compare continuous parametric variables, while comparisons between categorical variables were made by Fisher's exact test, and P < 0.05 was considered to indicate statistical significance for all tests. Statistical analysis was carried out using the Statistical Package for the Social Sciences (SPSS) software version 19.0 (IBM Corp., Armonk, NY, USA).
RESULTS
Baseline characteristics of the control and study groups did not differ significantly (Table 1) . Pain symptoms and endometriotic locations in the study group are reported in Table 2 . Transperineal ultrasound was performed successfully in all women, and no patients were excluded from the study as a result of discomfort.
The outcomes of static and dynamic PFM morphometry are summarized in Table 3 . Compared with the control group, patients with DIE showed a significantly smaller LHA at rest (P = 0.03). During Valsalva maneuver, LHA was significantly smaller (P < 0.01) and enlargement of the Data are given as mean ± SD or n (%). NS, not significant.
LHA from baseline was less marked (P = 0.01) in women with DIE. On PFM contraction, reduction in LHA was significantly smaller in women with DIE (P < 0.001). Persistent LAM coactivation during Valsalva maneuver was detected more frequently in women with DIE than in controls, although this outcome was at the borderline of statistical significance (16/50 (32.0%) vs 4/35 (11.4%); P = 0.05).
DISCUSSION
In our study, women with DIE showed increased PFM tonus and decreased PFM strength on 3D/4D transperineal ultrasound in comparison with healthy women. Compared with controls, women with DIE had a significantly smaller LHA at rest and during Valsalva maneuver, and showed smaller enlargement of the LHA during Valsalva, suggesting a PFM hypertone in women with DIE. Furthermore, they presented less reduction in LHA on PFM contraction, which may indicate loss of PFM strength. The PFM hypertonus detected at rest in women with DIE appears to influence PFM morphometry on dynamic examination.
The data obtained during Valsalva maneuver may also be influenced by the phenomenon of LAM coactivation, which entails a lack of adequate relaxation of the PFM on Valsalva with contraction of the LAM. Indeed, we observed a tendency to a higher rate of persistent LAM coactivation in women with DIE compared with controls, although this was at the limit of statistical significance (P = 0.05). Little has been reported about LAM coactivation in the literature.Örno and Dietz suggested that this phenomenon can be abolished in some cases by utilizing ultrasound as a biofeedback tool, together with oral instructions and repetition. Although the implications of this phenomenon are not completely understood, its persistence may lead to a paradoxical puborectalis contraction during evacuation, defined as anismus, which causes obstructed defecation 24 . DIE is a complex disease that is usually associated with pain, together with sexual, urinary and rectal dysfunction, adversely affecting the quality of life [2] [3] [4] [5] [6] [7] [8] . This broad range of dysfunction could partly be attributed to anomalies of relaxation and coordination of the PFM, including urinary and anal sphincters 25 . It is not clear whether PFM hypertonus is a cause or effect of the pelvic pain associated with DIE. Like other visceral pain syndromes responsible for chronic pelvic pain, DIE may be the cause of PFM hypertonus through central and peripheral sensitization and lowering of nociceptive thresholds, resulting in neuropathic upregulation, hypersensitivity and allodynia 25 . On the other hand, the pathophysiology of endometriosis-associated pain seems to be multifactorial, including nociceptive, inflammatory and neuropathic mechanisms [26] [27] [28] . However, it has been shown that pelvic floor hypertonic dysfunction can be an additional causal factor of a patient's pelvic pain, determining pelvic dysfunction and chronic pain 29 . In a recent study, Dos Bispo et al. 13 showed that women with DIE have increased prevalence of PFM spasms, as assessed by clinical examination. Assessment of the PFM using digital palpation may elicit pain, which may provoke a muscle contraction and, thus, misleading findings 10 . Our data demonstrate that 3D/4D transperineal ultrasound could be an objective, non-invasive instrument for the evaluation of PFM dysfunction in women with DIE, which does not involve exposure to radiation. In our series, no patient complained of discomfort during the transperineal ultrasound examination, during either static or dynamic evaluation. Moreover, transperineal ultrasound can be performed by a gynecologist without the need for other specialists, such as a radiologist. Although previous studies have analyzed the relationship between PFM dysfunction and pain with transperineal ultrasound 10, 11, 17 , this is the first to investigate PFM alterations in women with DIE. These data cannot be generalized because of the small sample size of the study population. However, the strengths of our study include its prospective design, exclusive selection of nulliparous women, presence of a control group of asymptomatic women without endometriosis, histological confirmation of endometriosis in the study group and blinding of the examiners reviewing the sonographic data.
In conclusion, our preliminary data show that women with DIE have smaller pelvic hiatal areas at rest and on Valsalva, suggesting a possible association between DIE and PFM dysfunction. Further studies on larger populations are needed in order to stratify this association by location of DIE, explore the potential value of ultrasound in reducing chronic pain associated with DIE through visual feedback and evaluate the benefits of integrating 3D/4D transperineal ultrasound into the routine work-up for patients with endometriosis.
